PHYSICAL COMPATIBILITY OF INTRAVENOUS ANTI-INFECTIVE DRUGS WITH MEDICATIONS COMMONLY USED IN INTENSIVE CARE UNITS
3PC-016
PHYSICOCHEMICAL STABILITY OF VANCOMYCIN HYDROCHLORIDE IN POLYPROPYLENE SYRINGES AT HIGH CONCENTRATIONS FOR INTENSIVE CARE UNITS
3PC-015
PHYSICOCHEMICAL STABILITY OF CEFOTAXIME IN POLYPROPYLENE SYRINGES AT HIGH CONCENTRATIONS FOR INTENSIVE CARE UNITS
3PC-014
STABILITY OF 1 MG/ML AND 4 MG/ML HYDROCORTISONE SOLIUM SUCCINATE SOLUTIONS IN 0.9% SODIUM CHLORIDE AND 5% GLUCOSE
3PC-013
FEEDBACK FROM A FEASIBILITY STUDY OF ALLERGY TEST PREPARATIONS IN DAY HOSPITALISATION
3PC-012
TOPICAL CIDOFOVIR COMPOUNDING CREAM FOR THE TREATMENT OF DISSEMINATED INFECTION BY MOLLUSCUM CONTAGIOSUM
3PC-011
EFFECTIVENESS OF 3% TOPICAL IMIQUIMOD IN OFF-LABEL USE FOR ORAL FLORIDA PAPILLOMATOSIS: A CASE REPORT
3PC-010
STABILITY OF CHLORHEXIDINE 0.05% EYE DROPS COMPOUNDING DRUG
3PC-009
SUCCESSFUL TREATMENT OF HAMARTOMA IN CHILD SYNDROME AFTER 30 MONTHS WITH TOPICAL ADMINISTRATION OF SIMVASTATIN/CHOLESTEROL CREAM: A CASE REPORT
3PC-008
PHYSICOCHEMICAL STABILITY OF NOREPINEPHRINE BITARTRATE IN POLYPROPYLENE SYRINGES AT HIGH CONCENTRATIONS FOR INTENSIVE CARE UNITS
3PC-007
IMPLEMENTATION AND QUALITY CONTROL OF A 5% FRUCTOSE AND 10% GLYCEROL STERILE SOLUTION FOR DIGESTIVE ENDOSCOPY
3PC-006
ANALYSIS OF THE REGIMENS ESTABLISHED AT THE PHARMACY SERVICE FOR TOTAL PARENTERAL NUTRITION AND THE USE OF GLUTAMINE AS SOURCE OF NITROGEN
3PC-005
STABILITY STUDY OF A 10% SODIUM BENZOATE ORAL SOLUTION
3PC-004
WHAT HAPPENS WHEN INSULIN ASPART IS DILUTED IN DEXTROSE?
3PC-003
WEIGHT-LOWERING PSEUDOEPHEDRINE-BASED PRESCRIPTIONS: MONITORING PATIENT FEEDBACK AFTER UPDATE OF NATIONAL PRICE LIST OF MEDICINES AND MAGISTRAL PREPARATION
